Biocon Pharma Limited receives FDA approval for Norepinephrine Bitartrate Injection USP, expanding its complex drug portfolio ...

Biocon added 1.34% to Rs 348.55 after the company's wholly owned subsidiary Biocon Pharma announced the receipt of U.S Food and Drug Administration (US FDA) approval for its ANDA Norepinephrine ...

Biocon's subsidiary has received approval from the US Food and Drug Administration (US FDA) for its ANDA Norepinephrine ...

Iptacopan is the first FDA-approved treatment for C3G, targeting the disease's underlying cause by inhibiting the alternative complement pathway. The phase 3 APPEAR-C3G study showed a 35.1% ...

This approval augments Biocon Pharma's complex injectables portfolio and reinforces its footprint in the US pharma market.

Animal studies could lead to blood tests that could guide doctors in better matching drugs to patients based on immune system ...

The U.S. Food and Drug Administration (FDA) has approved the first-ever testing kit for sexually transmitted infections that can be taken at home without a prescription. But it's not for everyone.

SSRIs/SNRIs make more of them available by slowing down reuptake, which is when they're absorbed back into the nerve cell after use. Of the FDA-approved drugs for FMS, two out of three are SNRIs. (No ...

Tevimbra plus chemotherapy was previously approved to treat advanced gastric and gastroesophageal junction cancers. Credit: Orawan Pattarawimonchai/Shutterstock. The ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved vutrisiran for the treatment of transthyretin amyloidosis with cardiomyopathy. Approval was ...